Novartis predicts a profit drop in 2026 due to expiring patents on key drugs. This will impact the company’s revenue and earnings in the future. Novartis is preparing for this expected decrease by investing in new innovative treatments and focusing on research and development efforts. Investors should keep an eye on the company’s strategy moving forward.

Read more at Investing.com: Novartis flags 2026 profit drop as patents for key drugs expire